Fetal growth restriction (FGR) complicates approximately 3-7% of pregnancies and is associated with increased perinatal morbidity and mortality, including a heightened risk of neurodevelopmental impairment. Identifying which fetuses are most vulnerable to brain injury remains a clinical challenge, necessitating improved antenatal surveillance strategies.
Fetal growth restriction (FGR), defined as a fetus failing to reach its genetic growth potential, is a significant obstetric complication. It is linked to adverse perinatal outcomes, including stillbirth, neonatal death, and long-term neurodevelopmental deficits.1 The underlying pathophysiology often involves placental insufficiency, leading to chronic hypoxia and nutrient deprivation.2 This chronic stress can trigger adaptive circulatory changes in the fetus, commonly referred to as 'brain sparing,' where blood flow is preferentially redirected to vital organs like the brain at the expense of other circulations.3 While initially protective, prolonged brain sparing can itself indicate significant fetal compromise and is associated with an increased risk of brain injury.4
FGR affects approximately 3-7% of pregnancies in developed countries and up to 20% in low-income settings, making it a global health concern. The clinical presentation of FGR can vary, from mild growth deceleration detected late in gestation to severe early-onset FGR with profound placental dysfunction. Identifying FGR early and accurately is crucial for timely intervention and improved outcomes. However, the diagnosis can be challenging, often relying on serial ultrasound measurements of fetal biometry, such as abdominal circumference and estimated fetal weight, which are then compared to population-based growth charts. The integration of Doppler ultrasound parameters provides a more dynamic assessment of fetal well-being and helps differentiate between constitutionally small fetuses and those with pathological growth restriction. This distinction is vital, as constitutionally small fetuses typically have normal Doppler findings and a lower risk of adverse outcomes compared to FGR fetuses with abnormal Doppler profiles.
Doppler Ultrasound in FGR Assessment
Doppler ultrasound is a non-invasive tool used to assess fetal haemodynamics, providing insights into placental function and fetal adaptation to hypoxia. Key parameters include the umbilical artery (UA) pulsatility index (PI), which reflects placental resistance, and the middle cerebral artery (MCA) PI, which indicates cerebral vascular resistance.5 The cerebroplacental ratio (CPR), calculated as MCA PI divided by UA PI, is considered a more sensitive marker of fetal compromise than either parameter alone, as it reflects the balance between placental resistance and cerebral vasodilation.6 A low CPR is indicative of brain sparing and is associated with adverse perinatal outcomes.7
Studies have consistently demonstrated that abnormal Doppler parameters, particularly a low CPR, correlate with an increased risk of neonatal brain injury in FGR fetuses. For instance, a reduced MCA PI, reflecting cerebral vasodilation, has been linked to an increased incidence of white matter injury (WMI) and intraventricular haemorrhage (IVH) in preterm FGR infants.8 WMI, characterised by damage to the developing white matter, is a major precursor to cerebral palsy and other neurodevelopmental impairments.9 Similarly, abnormal UA Doppler findings, such as absent or reversed end-diastolic flow, are strong predictors of severe placental insufficiency and are associated with higher rates of neonatal morbidity and mortality, including neurological complications.10 The mechanism by which brain sparing leads to injury is thought to involve a redistribution of blood flow that, while initially protective, can become detrimental over time. Chronic hypoxia and nutrient deprivation can lead to oxidative stress and inflammation, damaging the delicate developing brain tissue. Furthermore, the preferential shunting of blood to the brain may compromise other organs, such as the kidneys and gastrointestinal tract, contributing to broader systemic morbidity.
The utility of Doppler assessment extends beyond risk stratification; it also informs clinical management, particularly regarding the timing of delivery. In FGR pregnancies, serial Doppler surveillance helps clinicians monitor the progression of fetal compromise. Deterioration in Doppler parameters, such as a persistently low CPR or absent/reversed UA end-diastolic flow, often prompts earlier delivery to mitigate the risks of stillbirth and severe neurological injury.11 The decision to deliver is a balance between the risks of prematurity and the risks of continued intrauterine compromise. Doppler findings provide objective data to guide this complex decision-making process.12
While Doppler ultrasound is a valuable tool, it has limitations. The interpretation of Doppler waveforms requires expertise, and inter-observer variability can occur.13 Furthermore, while Doppler abnormalities identify fetuses at increased risk, they do not predict brain injury with 100% accuracy. Other factors, such as gestational age at delivery, severity of FGR, and postnatal complications, also influence neurodevelopmental outcomes.14 The sensitivity and specificity of Doppler parameters for predicting specific types of brain injury can vary, and a single abnormal finding may not be sufficient to warrant immediate intervention without considering the broader clinical picture. Additionally, the optimal timing and frequency of Doppler surveillance in different FGR phenotypes remain areas of ongoing research. Future research may focus on integrating Doppler parameters with other biomarkers and advanced imaging techniques, such as fetal MRI, to refine the prediction of brain injury and improve targeted interventions.15
The consistent evidence linking abnormal Doppler measures to an increased risk of brain injury in FGR fetuses underscores the necessity of integrating these assessments into routine antenatal care. For obstetricians, this is not merely an academic exercise; it is a direct call to action to refine surveillance protocols. Relying solely on growth parameters misses a critical window for intervention. The cerebroplacental ratio, in particular, offers a sensitive, non-invasive marker that can stratify risk and inform the delicate balance of when to deliver a compromised fetus, potentially reducing the burden of neurodevelopmental impairment.
The implications for patient care are substantial. Early identification of fetuses at high risk allows for more targeted counselling of parents regarding potential neonatal outcomes and facilitates preparation for specialised neonatal care. This proactive approach can lead to improved resource allocation in tertiary centres and better preparedness for the challenges of managing preterm FGR infants. While the technology is widely available, ensuring consistent training and adherence to standardised protocols for Doppler interpretation across all levels of care remains a practical challenge that guideline bodies like NICE and ACOG should address with updated recommendations.
From an industry perspective, the continued reliance on established, cost-effective technologies like Doppler ultrasound highlights the enduring value of foundational diagnostic tools. While there is a constant push for novel biomarkers and advanced imaging, the data reinforce that optimising the application of existing, accessible methods can yield significant clinical gains. Investment in training programmes and quality assurance for ultrasound practitioners may be more impactful in the short term than chasing the next 'breakthrough' technology that may not be widely implementable.
- The Pivot Doppler assessment of the cerebroplacental ratio (CPR) and middle cerebral artery (MCA) pulsatility index (PI) provides a non-invasive method to stratify brain injury risk in FGR.
- The Data Abnormal CPR and MCA PI are associated with an increased incidence of white matter injury and intraventricular haemorrhage in FGR.
- The Action Clinicians should integrate Doppler assessment into the routine monitoring of FGR pregnancies to inform delivery timing and neonatal management.
ART-2026-294
·07/26
This content is intended for healthcare professionals, clinical researchers, and life science industry professionals. Produced for informational and educational purposes only.

I cover NHS policy, NICE guidance, and the gap between what the evidence says and what gets commissioned. I bring a health economics background to reporting on how health systems make decisions under uncertainty.
Cite This Article
Mistry D, Voss M. Doppler measures identify brain injury risk in fetal growth restriction. The Life Science Feed. Published June 9, 2026. Updated July 23, 2026. Accessed July 24, 2026. https://thelifesciencefeed.com/obstetrics-and-gyn/pregnancy-complications/research/doppler-measures-spot-brain-risk-fgr.
Editorial & AI Standards
All content is researched from peer-reviewed, open-access sources: published trial data, clinical guidelines, and regulatory filings. AI tools are used solely to structure and summarise that evidence; no AI-generated conclusions appear without editor verification against the primary source.
Every article is reviewed by a named editor before publication. Source citations are listed in the References section. This content does not represent the views of any pharmaceutical company, medical device manufacturer, or healthcare provider.
Licence & Rights
© 2026 The Life Science Feed. All rights reserved. Unless otherwise indicated, all content is the property of The Life Science Feed and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission.
Medical Disclaimer
The information provided on The Life Science Feed is for educational and informational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider regarding any medical condition or treatment decision. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
References
1. Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2013;42(3):296-300.
2. Kingdom JC, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta. 1997;18(7):605-612. doi:10.1016/s0143-4004(97)90000-x
3. Baschat AA, Gembruch U, Harman CR. The cerebroplacental ratio revisited. Ultrasound Obstet Gynecol. 2001;17(2):189-191.
4. Figueras F, Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol. 2011;204(4):288-300. doi:10.1016/j.ajog.2010.08.055
5. Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med. 2000;342(1):9-14. doi:10.1097/00006254-200006000-00005
6. Baschat AA. The cerebroplacental ratio: is it the holy grail? Ultrasound Obstet Gynecol. 2013;42(3):263-265.
7. Prior T, Mullins E, Bennett P, et al. Prediction of stillbirth and adverse perinatal outcomes in fetal growth restriction: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;41(3):285-294.
8. Cruz-Martinez R, Figueras F, Oros D, et al. Fetal brain Doppler to predict neonatal brain injury in severe preterm fetal growth restriction. Ultrasound Obstet Gynecol. 2011;38(3):294-298.
9. Volpe JJ. Brain injury in the premature infant: from pathogenesis to prevention. Brain. 2009;132(Pt 6):1388-1411.
10. Karsdorp VH, van Vugt JM, van Geijn HP. Clinical significance of absent or reversed end diastolic flow in the umbilical artery. Lancet. 1994;344(8932):1056-1060. doi:10.1016/s0140-6736(94)90457-x
11. Grivell RM, Dodd JM, Robinson JS. Antenatal surveillance in pregnancies with suspected fetal compromise: a systematic review and meta-analysis. Cochrane Database Syst Rev. 2012;(6):CD007128.
12. Baschat AA. Fetal growth restriction: definitions, diagnosis, and management. Semin Perinatol. 2011;35(5):235-245.
13. Bhide A, Acharya G, Bilardo CM, et al. ISUOG Practice Guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. 2023;61(1):151-167.
14. Gardosi J, Chang A, Kalyan B, et al. Customised antenatal growth charts. Lancet. 1992;339(8788):283-287. doi:10.1016/0140-6736(92)91342-6
15. Story L, Gholipour F, Garel C, et al. Fetal brain magnetic resonance imaging in growth restriction: a systematic review. Ultrasound Obstet Gynecol. 2021;58(2):188-199.





